Dr. Reddy's Laboratories enters into trade generics business in India

23 Jun 2023 Evaluate

Dr. Reddy's Laboratories has entered into the trade generics business in India with the launch of its new dedicated division ‘RGenX’. Through this, Dr. Reddy’s aims to provide patients with access to a wider range of products and increased affordability. The new business will further the company’s goal of reaching over 1.5 billion patients by 2030.

Dr. Reddy’s aims to roll out its trade generics across cities and towns in India, including rural areas. The company will work closely with its channel partners to ensure availability of its products.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1267.05 1.10 (0.09%)
31-Dec-2025 10:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1722.40
Dr. Reddys Lab 1267.05
Cipla 1498.15
Zydus Lifesciences 913.45
Lupin 2086.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×